TABLE 2

Estimated population prevalence of airflow obstruction and spirometric restriction in 19 sites of the BOLD study with good quality spirometry and data on history of tuberculosis (at least five cases)

Tirana, AlbaniaAnnaba, AlgeriaSalzburg, AustriaVancouver, BC, CanadaGuangzhou, ChinaLondon, UKTartu, EstoniaHannover, GermanyReykjavik, IcelandPune, IndiaFes, MoroccoMaastricht, the NetherlandsManila, the PhilippinesNampicuan and Talugtug, the PhilippinesKrakow, PolandLisbon, PortugalCape Town, South AfricaUppsala, SwedenLexington, KY, USA
Subjects n9398901253827461675613680757845768590892722526711846547508
Airflow obstruction %8.96.417.413.57.617.66.18.211.36.18.918.89.415.213.58.319.59.614.4
Spirometric restriction %16.126.59.38.529.917.88.59.012.566.119.310.162.756.710.110.746.710.226.2
Response rate# %82.394.665.026.087.017.049.059.081.097.098.048.058.085.578.010.063.061.014.0
Cooperation rate %84.094.667.051.087.037.070.061.084.097.098.055.058.086.279.027.068.063.027.0
  • Airflow obstruction was defined as a forced expiratory volume in 1 s/forced vital capacity (FVC) ratio below the lower limit of normal (LLN). Spirometric restriction was defined as an FVC below the LLN. BOLD: Burden of Obstructive Lung Disease. #: denominator comprises people of unknown eligibility status who could not be contacted; only known participants considered ineligible were excluded. : denominator comprises only participants who were contacted and eligible.